T1	Participants 59 92	patients with Alzheimer's disease
T2	Participants 114 152	patients with Alzheimer's disease (AD)
T3	Participants 348 359	AD patients
T4	Participants 891 902	AD patients
T5	Participants 950 961	AD patients
